POLYCYSTIC OVARY SYNDROME

By Okonkwo Chinenye Maryrose RN, RM, RNAS, PDE, TRCN Directress/ Proprietress, Nneoma Maternity inc. and Member, National Association of Nigerian Nurses and Midwives and Association of General Private Nursing Practitioners.
Date: 23/8/2024
A Presentation to the Women’s Wing of Charis World Bible Church, Oko


Polycystic Ovary Syndrome (PCOS) is a common hormonal disorder affecting women of reproductive age. It is characterized by a combination of symptoms that may include irregular menstrual periods, excess androgen levels (male hormones), and polycystic ovaries. Despite its name, not all women with PCOS have ovarian cysts, and the condition can vary widely in its presentation.

REFERENCES

  • Teede, H. J., Misso, M. L.., Costello, M. F., Dokras, A., Laven, J., Moran, L., & Miltonen, T. (2018). Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Human Reproduction, 33(9), 1602-1618. https://doi.org/10.1093/bumrep/dey256
  • Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azriz, I. (2011), Polycystic ovary syndrome: Etiology, pathogenesis, and diagnosis. Nature Reviews Endocrinology, 7(4), 219-231, https://doi.org/10.1038/nrendo.2010.217
  • Escobar-Morreale, H. F. (2018). Polycystic ovary syndrome: Definition, aetiology, diagnosis and treatment. Nature Reviews Endocrinology, 14(5), 270-284. https://doi.org/10.1038/nrendo.2018.24
  • Fauser, B, C., Tarlatzis, B, C., Rebar, R. W., Legro, R. S., Balen, A. M., Lobo, R., & ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2012). Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): The Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertility and Sterility, 97(1), 28-38. https://doi.org/10.1016/j.ferinstert. 2011.00.024
  • Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction, 19(1), 41-47. https://doi.org/10.1093/humrep/deh098
  • Santoro, N., Epperson, C. N., & Mathews, S. B. (2015). Menopausal symptoms and their management. Endocrinology and Metabolism Clinics of North America, 44(3), 497-515. https://doi.org/10.1016/j.ecl.2015.05.001
  • Burger, H. G., Hale, G. E., Robertson, D. M., & Dennerstein, L. (2007). A review of hormonal changes during the menopausal transition: Focus on findings from the Melbourne Women’s Midlife Health Project. Human Reproduction Update, 13(6), 559-565. https://doi.org/10.1093/humupd/dmm020
  • Nelson, H. D. (2008). Menopause. Lancet, 371(0614), 760-770. https://doi.org/10.1016/S0140-6736(08)60346-3
  • Grady, D., & Sawaya, G. F. (2005). Estrogen and progestin therapy in postmenopausal women. Annual Review of Medicine, 50, 167-178. https://doi.org/10.1146/annurev.med.56,082103.104059
  • North American Menopause Society. (2017). The 2017 hormone therapy position statement of The North American Menopause Society. Menopause, 24(7), 728-753. https://doi.org/10.1097/GME.0000000000000921